Policy Issues in the Development and Adoption of Biomarkers for Molecularly Targeted Cancer Therapies
Sharyl J. Nass, Jonathan Phillips, and Margie Patlak, Rapporteurs; National Cancer Policy Forum; Board on Health Care Services; Institute of Medicine
2015 | ISBN: 030936857X | 106 pages | PDF | 1,5 MB
A long-held goal in oncology has been to develop therapies that target the specific abnormalities in each patient's cancer rather than simply treating cancers based on the tissue of origin. In the past decade, advances in technology have enabled researchers to relatively quickly and inexpensively determine, in minute detail, the genetic makeup of tumors.